Jeremy Schenkein, MD
Pulmonary Disease · Mechanicsville, VANPI 1851319180
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $98,672 of the $114,014 with a category attached, or 86.5%. GSK accounts for 88.5% of it on its own, with 38 other manufacturers making up the rest. Reporting peaked in 2023 at $24,809 and has fallen 84.4% since, to $3,860 in 2025. Among pulmonary disease clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 637 payments — averaging $178.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$101K
- AstraZeneca$2K
- Viiv Healthcare Company$2K
- Intuitive Surgical$1K
- Mylan Specialty L.p.$1K
- Medical Device Business Services, Inc.$975
- plus $6K from 33 others
What the payments were for
- Speaking & faculty fees$98,67287%
- Travel & lodging$2,8673%
- Food & beverage$12,23811%
- Education$2370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 199 | $100,847 |
| AstraZeneca | 91 | $1,825 |
| Viiv Healthcare Company | 1 | $1,600 |
| Intuitive Surgical | 5 | $1,199 |
| Mylan Specialty L.p. | 26 | $1,105 |
| Medical Device Business Services, Inc. | 4 | $975 |
| Boehringer Ingelheim | 41 | $846 |
| Sanofi | 36 | $749 |
| Novartis | 38 | $682 |
| Grifols USA, LLC | 21 | $428 |
| Insmed, Inc. | 22 | $401 |
| Amgen | 15 | $359 |
| Regeneron Healthcare Solutions, Inc. | 15 | $336 |
| Genentech USA, Inc. | 16 | $299 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $272 |
| Baxter Healthcare | 8 | $236 |
| Pfizer | 13 | $220 |
| Actelion Pharmaceuticals US, Inc. | 6 | $201 |
| United Therapeutics Corporation | 6 | $182 |
| Mallinckrodt Hospital Products Inc. | 7 | $142 |
| Paratek Pharmaceuticals, Inc. | 6 | $111 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Pulmonx Corporation | 3 | $94 |
| Viatris Specialty LLC | 5 | $89 |
| Pharming Healthcare, Inc. | 5 | $87 |
| Electromed, Inc. | 6 | $85 |
| AbbVie | 4 | $82 |
| Vifor Pharma, Inc. | 4 | $74 |
| Johnson & Johnson(2 entities) | 4 | $69 |
| Philips North America LLC | 4 | $61 |
| Sunovion Pharmaceuticals Inc. | 3 | $52 |
| Gilead | 3 | $41 |
| Nabriva Therapeutics, PLC | 2 | $38 |
| Verona Pharma, Inc. | 2 | $36 |
| Circassia Inc. | 2 | $30 |
| Merck | 1 | $19 |
| Inogen, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Advanced Respiratory, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$70,814
- Da Vinci Surgical System$1,171
- MONARCH$926
- Yupelri$722
- AIRSUPRA$303
- FASENRA$303
- TEZSPIRE$303
- TAGRISSO$195
- BREZTRI$108
How this compares
$114,014 in reported general payments places this provider in the 95th percentile of 317 pulmonary disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 855 | $680,500 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 213 | $179,443 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 337 | $167,015 |
| OfevNintedanib Esylate | 12 | $159,825 |
| Breo ElliptaFluticasone/Vilanterol | 297 | $140,755 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 151 | $104,435 |
| Spiriva RespimatTiotropium Bromide | 127 | $79,571 |
| SymbicortBudesonide/Formoterol Fumarate | 112 | $39,754 |
| Spiriva HandihalerTiotropium Bromide | 29 | $28,570 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 144 | $22,129 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 750 | $18,152 |
| Wixela InhubFluticasone Propion/Salmeterol | 145 | $14,387 |
| EliquisApixaban | 21 | $12,144 |
| Incruse ElliptaUmeclidinium Bromide | 33 | $11,588 |
| Arnuity ElliptaFluticasone Furoate | 41 | $10,265 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta | $100,847 | $1,010,1221,563 claims |
| Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat, Combivent Respimat | $846 | $352,322306 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,825 | $226,131337 claims |
| PfizerEliquis | $220 | $12,14421 claims |
| MerckDulera | $19 | $5,72212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 317 pulmonary disease providers in Virginia.
Other pulmonary disease in Mechanicsville
- Drew JonesMechanicsville$16K
- Ernesto GonzalezMechanicsville$16K
- Johnny WongMechanicsville$14K
- Steven NathanFalls Church$1.5M
- Omar MinaiHopewell$1.3M
- Rabih HalabiFalls Church$604K
- Eric LibreAnnandale$302K
- Sujoy GillRichmond$296K
- Imre NothCharlottesville$256K
- Carlos SilvaChesapeake$245K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.